Challenges to the global control of tuberculosis
暂无分享,去创建一个
Donald A Enarson | Toru Mori | D. Enarson | C. Chiang | Chen-Yuan Chiang | Catharina Van Weezenbeek | Toru Mori | C. van Weezenbeek | Donald A. Enarson
[1] E. Blas,et al. Equity, social determinants and public health programmes. , 2010 .
[2] H-H Lin,et al. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools [State of the art series. Operational research. Number 8 in the series]. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] C. Dye,et al. Global tuberculosis control: surveillance planning financing. WHO report 2003. , 2003 .
[4] Susan S. Ellenberg. Food and Drug Administration (FDA) , 2005 .
[5] M. Uplekar,et al. Private GPs contribute to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] T. Lu,et al. Assessing the quality of tuberculosis-related underlying cause of death assignment in Taiwan, 2001-2005. , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.
[7] P. Fujiwara,et al. Tuberculosis bacteriology--priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[8] A. Harries,et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review , 2011, BMC medicine.
[9] M. Borgdorff,et al. Establishment and development of the National Tuberculosis Control Programme in Vietnam. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[10] J. Salomon,et al. Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation , 2012, PLoS medicine.
[11] Wei Min Zhang,et al. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] F. Cobelens,et al. National survey of tuberculosis prevalence in Viet Nam. , 2010, Bulletin of the World Health Organization.
[13] Yu Wang,et al. National survey of drug-resistant tuberculosis in China. , 2012, The New England journal of medicine.
[14] J. V. Gorkom. Rapid Implementation of the Xpert MTB/RIF diagnostic test , 2012 .
[15] D. Chin,et al. Model collaboration between hospitals and public health system to improve tuberculosis control in China. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] T. Lin,et al. The impact of national health insurance on the notification of tuberculosis in Taiwan. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[17] Same-day diagnosis of tuberculosis by microscopy —Policy statement— , 2011 .
[18] H. S. Schaaf,et al. Management of drug-resistant tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] Eduardo Gotuzzo,et al. Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.
[20] P. Hopewell,et al. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.
[21] D. Enarson,et al. The FIDELIS initiative: innovative strategies for increased case finding. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] A. Ramsay,et al. A Multi-Country Non-Inferiority Cluster Randomized Trial of Frontloaded Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis , 2011, PLoS medicine.
[23] R. Jou,et al. External quality assessment of sputum smear microscopy in Taiwan. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] T. T. Dieu,et al. Public-private mix for improved TB control in Ho Chi Minh City, Vietnam: an assessment of its impact on case detection. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[25] S. Shin,et al. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[26] B G Williams,et al. Measuring tuberculosis burden, trends, and the impact of control programmes. , 2008, The Lancet. Infectious diseases.
[27] Philippe Glaziou,et al. Tuberculosis control and elimination 2010–50: cure, care, and social development , 2010, The Lancet.
[28] H. Schünemann,et al. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis , 2011 .
[29] J. Janssens,et al. An ecological analysis of incidence of tuberculosis and per capita gross domestic product , 2008, European Respiratory Journal.
[30] M. Uplekar,et al. Hard gains through soft contracts: productive engagement of private providers in tuberculosis control. , 2006, Bulletin of the World Health Organization.
[31] S. Blower,et al. Predicting the future of XDR tuberculosis. , 2007, The Lancet. Infectious diseases.
[32] D. Enarson,et al. Successful management of a national tuberculosis programme under conditions of war. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[33] L. Thomson,et al. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[34] L. Gabbasova,et al. Global tuberculosis report (2014) , 2014 .
[35] D. Enarson,et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[36] H. Rieder,et al. Highly Effective , and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis , 2010 .
[37] M. D. Granado,et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update , 2011, European Respiratory Journal.
[38] D. Enarson,et al. Comprehensiveness of primary services in the care of infectious tuberculosis patients in Rawalpindi, Pakistan. , 2011, Public health action.
[39] D. Enarson,et al. Why are tuberculosis patients not treated earlier? A study of informal health practitioners in Bangladesh. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[40] M. Uplekar,et al. Engaging all health care providers in TB control. Guidance on implementing public-private mix approaches. , 2006 .
[41] Z. Fatmi,et al. Implementing a public-private mix model for tuberculosis treatment in urban Pakistan: lessons and experiences. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[42] E. Bateman,et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[43] N. Schwalbe,et al. Implications of the current tuberculosis treatment landscape for future regimen change. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[44] M. Kimerling,et al. Hospital DOTS linkage in Indonesia: a model for DOTS expansion into government and private hospitals. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[45] SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY , 2010 .
[46] C. Simpson,et al. External quality assessment. , 1992, Journal of clinical pathology.
[47] M. Uplekar,et al. Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[48] P. Chou,et al. Completeness and timeliness of tuberculosis notification in Taiwan , 2011, BMC public health.
[49] P. Dewan,et al. Initial default among diagnosed sputum smear-positive pulmonary tuberculosis patients in Andhra Pradesh, India. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[50] E Declercq,et al. Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh. , 2006, Bulletin of the World Health Organization.
[51] D. Enarson. Principles of IUATLD collaborative tuberculosis progammes. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.
[52] I. Kantor. DR-TB drugs under the microscope: Sources and prices for drug - resistant tuberculosis medicines , 2013 .
[53] F. Cobelens,et al. Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[54] A. Nunn,et al. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial , 2004, The Lancet.
[55] A. Van Deun,et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. , 2010, American journal of respiratory and critical care medicine.
[56] I. Onorato,et al. Completeness and timeliness of tuberculosis case reporting. A multistate study. , 2001, American journal of preventive medicine.
[57] M. Uplekar,et al. Public-private mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[58] W. Bishai,et al. New drugs for the treatment of tuberculosis: hope and reality. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[59] A. Van Deun,et al. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[60] M. Murray,et al. Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies , 2008, PLoS medicine.
[61] C. Dye,et al. Tuberculosis: the role of risk factors and social determinants. , 2010 .
[62] C. Leung,et al. Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis? , 2009, European Respiratory Journal.
[63] E. Botha,et al. Initial default from tuberculosis treatment: how often does it happen and what are the reasons? , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[64] G. Leung,et al. Diabetic control and risk of tuberculosis: a cohort study. , 2008, American journal of epidemiology.
[65] A. Clarke,et al. An evaluation of completeness of tuberculosis notification in the United Kingdom , 2003, BMC public health.
[66] N. Trejos,et al. Missed opportunities for tuberculosis diagnosis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[67] A. Trébucq,et al. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[68] A. Trébucq,et al. A survey of TB services in hospitals in seven large cities in Asia and North Africa. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[69] J. Kongerud,et al. Deaths from active tuberculosis: can we rely on notification and mortality figures? , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[70] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[71] M. Kimerling,et al. Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries , 2011, PloS one.
[72] M. Pai,et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. , 2011, American journal of respiratory and critical care medicine.